The Schall Law Firm Encourages Shareholder Participation In A Securities Fraud Case Against Applied Therapeutics, Inc.
Portfolio Pulse from
The Schall Law Firm is urging shareholders of Applied Therapeutics, Inc. to participate in a class action lawsuit alleging securities fraud. The lawsuit claims violations of the Securities Exchange Act of 1934, targeting investors who bought shares between January 3, 2024, and December 2, 2024.
December 20, 2024 | 10:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Applied Therapeutics, Inc. is facing a class action lawsuit for alleged securities fraud, which could negatively impact its stock price in the short term.
The lawsuit against Applied Therapeutics for alleged securities fraud is significant, as it involves potential violations of the Securities Exchange Act. Such legal issues can lead to negative investor sentiment and potential financial liabilities, likely causing a short-term decline in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100